BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs3825942
,
SNCA
,
Apoptosis
,
Leukemia
,
Lung
,
Hematopoietic cell
,
Phenobarbital
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
palonosetron
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
HTR3A
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
5-hydroxytryptamine 3 receptor, A subunit
5-hydroxytryptamine 3 receptor
serotonin-activated cation-selective channel complex
amine binding
MODULE_215
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Drug target sets for approved compounds
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
Explore Curated Studies Results
Literature
Most Relevant Literature
Stability indicating potentiometric method for the determination of palonosetron HCl using two diffe…
Evaluation of contemporary olanzapine- and netupitant/palonosetron-containing antiemetic regimens fo…
Dexamethasone-sparing regimens with NEPA (netupitant/palonosetron) for the prevention of chemotherap…
Palonosetron as prophylaxis for post-discharge nausea and vomiting: a prospective, randomised, doubl…
Ocular Administration of Palonosetron in the Prevention of Cisplatin-Induced Nausea and Vomiting.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Intravenous Palonosetron With Radiotherapy and Concomitant Temozolomide
Palonosetron for Prevention of Biochemotherapy Induced Nausea and Vomiting
Palonosetron and Hydroxyzine to Reduce Opioid Withdrawal
Palonosetron and Blood Coagulation
Intensive Medicines Monitoring Project of Palonosetron Hydrochloride Capsules (Ruo Shan®)
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ